![]() | ![]() |
Piramal Pharma to Operate its Digwal Facility on Biomass Briquettes to Promote Sustainability
This achievement marks a substantial step toward Piramal's sustainability goal to reduce Scope 1 and 2 greenhouse gas (GHG) emissions by 42 percent by 2030.
Piramal Pharma | 16/01/2025 | By Aishwarya
Piramal Pharma Gets SBTi Approval for its GHG Emission Reduction Targets
Piramal Pharma Ltd. has committed to reduce absolute scope 1 and 2 GHG emissions 42 percent by FY2030 from a FY2022 base year.
Piramal Pharma | 17/09/2024 | By Aishwarya | 100
Piramal Pharma Gets EIR from US FDA for Bethlehem Plant
The EIR report signifies the closure of the inspection.
Piramal Pharma | 10/11/2023 | By Manvi | 468
Piramal Pharma gets EIR from US FDA for Sellersville, USA facility
The inspection has now been successfully closed by the US FDA
Piramal Pharma | 19/04/2023 | By Sudeep Soparkar | 534
Piramal Pharma gets EIR for Lexington, Kentucky facility
The inspection has been successfully completed<br />
Piramal Pharma | 20/02/2023 | By Sudeep Soparkar | 468
Piramal Pharma's Lexington facility gets six observations from US FDA
The observations were classified under VAI (Voluntary Action Indicated) and do not relate to data integrity<br />
Piramal Pharma | 17/01/2023 | By Sudeep Soparkar | 229
Piramal Pharma gets zero observations from US FDA for Riverview, Michigan facility
The inspection was completed successfully with Zero Form - 483 observations
Piramal Pharma | 11/11/2022 | By Sudeep Soparkar | 394
Piramal Pharma Solutions opens API plant in Ontario
The new plant, built as part of a CAD 30 million capital investment in the Aurora site, features more than ten thousand square feet of new manufacturing space
Piramal Pharma | 12/07/2022 | By Sudeep Soparkar | 525
Piramal Pharma inducts Peter Stevenson, Nathalie Leitch and Sridhar Gorthi to its board
The appointments will add to the well-diversified experience that currently exists on the PPL board
Piramal Pharma | 07/07/2022 | By Sudeep Soparkar | 476
Piramal Pharma Solutions appoints Herve Berdou as COO
Berdou will be based in the Northeastern US
Piramal Pharma's pharma solutions business announced the appointment of Herve Berdou as Chief Operating Officer, Piramal Pharma Solutions (PPS).
Piramal Pharma | 22/06/2022 | By Sudeep Soparkar | 265
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy